BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Metabolism of nitric oxide
,
Bleomycin
,
rs6983267
,
MDM2
,
Coagulation
,
Retina
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
antibodies neoplasm
Summary
General Info
Curated Studies
Most Correlated Studies
Chronic lymphocytic leukemia (CLL) tumors: progressors and non-progressors
Drug target sets for approved compounds
PBMCs of T-cell prolymphocytic leukemia patients pre- and post- alemtuzumab and cladribine treatment
GSK cancer cell line transcript profiling
Gastric carcinoma NCI-N87 cells showing sensitivity or resistance to trastuzumab
Explore Curated Studies Results
Literature
Most Relevant Literature
Zajdela hepatoma cells cultured in vitro].
Monoclonal antibodies: potential new therapeutic treatment against multiple myeloma.
Jaw clenching' in anti-Ri--antibody-associated paraneoplastic syndrome.
Functionalized magnetic nanoparticles for the detection and quantitative analysis of cell surface an…
Does a "thiol shield" protect tumors from natural IgM antibody, and, if so, how can it be suppressed…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Nimotuzumab in EGFR Highly Expressed Pancreatic Neuroendocrine Neoplasms
Oncogenic Role of Engrailed (EN)-2 in Epithelial Ovarian Neoplasms
KSD-101 Therapy for EBV-associated Haematologic Neoplasms: an Exploratory Clinical Trial
PD-1 Inhibition in Advanced Myeloproliferative Neoplasms
Chemotherapy Combined With Apatinib and PD-1 Antibody
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ